{"id":"https://openalex.org/W4388899080","doi":"https://doi.org/10.1200/po.23.00091","title":"Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1/2, Germline PALB2, or Homologous Recombination Deficiency Signature","display_name":"Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1/2, Germline PALB2, or Homologous Recombination Deficiency Signature","publication_year":2023,"publication_date":"2023-09-01","ids":{"openalex":"https://openalex.org/W4388899080","doi":"https://doi.org/10.1200/po.23.00091","pmid":"https://pubmed.ncbi.nlm.nih.gov/37992259","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10681426"},"language":"en","primary_location":{"id":"doi:10.1200/po.23.00091","doi":"https://doi.org/10.1200/po.23.00091","is_oa":true,"landing_page_url":"https://doi.org/10.1200/po.23.00091","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/PO.23.00091?role=tab","source":{"id":"https://openalex.org/S4210227748","display_name":"JCO Precision Oncology","issn_l":"2473-4284","issn":["2473-4284"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precision Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/PO.23.00091?role=tab","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019375343","display_name":"Felipe Batalini","orcid":"https://orcid.org/0000-0003-3354-308X","observed_orcids":["https://orcid.org/0000-0003-3354-308X"]},"institutions":[{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Felipe Batalini","raw_affiliation_strings":["Mayo Clinic, Phoenix, AZ"],"raw_orcid":"https://orcid.org/0000-0003-3354-308X","affiliations":[{"raw_affiliation_string":"Mayo Clinic, Phoenix, AZ","institution_ids":["https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032009066","display_name":"Russell William Madison","orcid":"https://orcid.org/0000-0002-7838-2526","observed_orcids":["https://orcid.org/0000-0002-7838-2526"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Russell W. Madison","raw_affiliation_strings":["Foundation Medicine, Inc, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-7838-2526","affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Boston, MA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067701996","display_name":"Ethan S. Sokol","orcid":"https://orcid.org/0000-0002-5480-8473","observed_orcids":["https://orcid.org/0000-0002-5480-8473","https://orcid.org/0000-0002-2988-0537"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ethan S. Sokol","raw_affiliation_strings":["Foundation Medicine, Inc, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-2988-0537","affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Boston, MA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066365655","display_name":"Dexter X. Jin","orcid":"https://orcid.org/0000-0001-6545-1580","observed_orcids":["https://orcid.org/0000-0001-6545-1580"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dexter X. Jin","raw_affiliation_strings":["Foundation Medicine, Inc, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0001-6545-1580","affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Boston, MA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086972914","display_name":"Kuei\u2010Ting Chen","orcid":"https://orcid.org/0009-0003-7558-2447","observed_orcids":["https://orcid.org/0009-0003-7558-2447"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kuei-Ting Chen","raw_affiliation_strings":["Foundation Medicine, Inc, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Boston, MA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012877447","display_name":"Brennan James Decker","orcid":"https://orcid.org/0000-0003-4516-7421","observed_orcids":["https://orcid.org/0000-0003-4516-7421"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brennan Decker","raw_affiliation_strings":["Foundation Medicine, Inc, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0003-4516-7421","affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Boston, MA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032268177","display_name":"Dean C. Pavlick","orcid":"https://orcid.org/0000-0001-6075-6246","observed_orcids":["https://orcid.org/0000-0001-6075-6246"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dean C. Pavlick","raw_affiliation_strings":["Foundation Medicine, Inc, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0001-6075-6246","affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Boston, MA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071731260","display_name":"Garrett Michael Frampton","orcid":"https://orcid.org/0000-0002-2361-2750","observed_orcids":["https://orcid.org/0000-0002-2361-2750"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Garrett M. Frampton","raw_affiliation_strings":["Foundation Medicine, Inc, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-2361-2750","affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Boston, MA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018472888","display_name":"Gerburg M. Wulf","orcid":"https://orcid.org/0000-0001-7868-6231","observed_orcids":["https://orcid.org/0000-0001-7868-6231"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerburg M. Wulf","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0001-7868-6231","affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005206482","display_name":"Judy Ellen Garber","orcid":"https://orcid.org/0000-0001-9449-3982","observed_orcids":["https://orcid.org/0000-0001-9449-3982"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judy E. Garber","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0001-9449-3982","affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045665778","display_name":"Geoffrey R. Oxnard","orcid":"https://orcid.org/0000-0003-1054-8240","observed_orcids":["https://orcid.org/0000-0003-1054-8240"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey Oxnard","raw_affiliation_strings":["Foundation Medicine, Inc, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0003-1054-8240","affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Boston, MA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062019987","display_name":"Alexa Betzig Schrock","orcid":"https://orcid.org/0000-0003-0106-9096","observed_orcids":["https://orcid.org/0000-0003-0106-9096"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexa B. Schrock","raw_affiliation_strings":["Foundation Medicine, Inc, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0003-0106-9096","affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc, Boston, MA","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051532432","display_name":"Nadine Tung","orcid":"https://orcid.org/0000-0003-1422-3734","observed_orcids":["https://orcid.org/0000-0003-1422-3734"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nadine M. Tung","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0003-1422-3734","affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5019375343"],"corresponding_institution_ids":["https://openalex.org/I4210127938"],"apc_list":null,"apc_paid":null,"fwci":2.6976,"has_fulltext":true,"cited_by_count":23,"citation_normalized_percentile":{"value":0.92180311,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"7","issue":"7","first_page":"e2300091","last_page":"e2300091"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.019600000232458115,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.9300000071525574},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8970000147819519},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8960000276565552},{"id":"https://openalex.org/keywords/brca-mutations","display_name":"BRCA mutations","score":0.7490000128746033},{"id":"https://openalex.org/keywords/palb2-mutation","display_name":"PALB2 mutation","score":0.824999988079071},{"id":"https://openalex.org/keywords/homologous-recombination-repair-genes","display_name":"homologous recombination repair genes","score":0.8840000033378601},{"id":"https://openalex.org/keywords/biallelic-loss","display_name":"biallelic loss","score":0.800000011920929},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8289999961853027},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9919999837875366},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.7979999780654907},{"id":"https://openalex.org/keywords/comprehensive-genomic-profiling","display_name":"comprehensive genomic profiling","score":0.671999990940094},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.7039999961853027},{"id":"https://openalex.org/keywords/parp-inhibitor-resistance","display_name":"PARP inhibitor resistance","score":0.4620000123977661},{"id":"https://openalex.org/keywords/treatment-de-escalation","display_name":"treatment de-escalation","score":0.3840000033378601}],"concepts":[{"id":"https://openalex.org/C2778144015","wikidata":"https://www.wikidata.org/wiki/Q18046302","display_name":"PALB2","level":5,"score":0.9133996367454529},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6389032602310181},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.5955320596694946},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5600674748420715},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.554940402507782},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.5269573330879211},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4685676395893097},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46298137307167053},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4321712851524353},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.42361265420913696},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4165528118610382},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.386488676071167},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38188254833221436},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36709898710250854},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.3289113938808441},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.30957889556884766},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3006027936935425},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.2690623998641968},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2625359892845154},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.06458652019500732},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000076164","descriptor_name":"Fanconi Anemia Complementation Group N Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018095","descriptor_name":"Germ-Line Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019398","descriptor_name":"Genes, BRCA1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024522","descriptor_name":"Genes, BRCA2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059765","descriptor_name":"Homologous Recombination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1200/po.23.00091","doi":"https://doi.org/10.1200/po.23.00091","is_oa":true,"landing_page_url":"https://doi.org/10.1200/po.23.00091","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/PO.23.00091?role=tab","source":{"id":"https://openalex.org/S4210227748","display_name":"JCO Precision Oncology","issn_l":"2473-4284","issn":["2473-4284"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precision Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10681426","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10681426","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precis Oncol","raw_type":"Text"},{"id":"pmid:37992259","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37992259","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO precision oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1200/po.23.00091","doi":"https://doi.org/10.1200/po.23.00091","is_oa":true,"landing_page_url":"https://doi.org/10.1200/po.23.00091","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/PO.23.00091?role=tab","source":{"id":"https://openalex.org/S4210227748","display_name":"JCO Precision Oncology","issn_l":"2473-4284","issn":["2473-4284"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precision Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306260","display_name":"Breast Cancer Research Foundation","ror":"https://ror.org/0348ff195"},{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320309045","display_name":"Adrienne Helis Malvin Medical Research Foundation","ror":"https://ror.org/0359t7090"},{"id":"https://openalex.org/F4320319515","display_name":"Seagen","ror":null},{"id":"https://openalex.org/F4320319736","display_name":"Invitae","ror":"https://ror.org/05mt7ye26"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320334461","display_name":"Foundation Medicine","ror":"https://ror.org/02ackr434"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388899080.pdf","grobid_xml":"https://content.openalex.org/works/W4388899080.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1973268287","https://openalex.org/W2074952360","https://openalex.org/W2109772731","https://openalex.org/W2117964602","https://openalex.org/W2147629880","https://openalex.org/W2160981405","https://openalex.org/W2168409298","https://openalex.org/W2621271973","https://openalex.org/W2749641460","https://openalex.org/W2754327139","https://openalex.org/W2786268518","https://openalex.org/W2886477543","https://openalex.org/W2897430921","https://openalex.org/W2913584903","https://openalex.org/W2938929416","https://openalex.org/W2939332654","https://openalex.org/W2975141952","https://openalex.org/W3004480399","https://openalex.org/W3021534941","https://openalex.org/W3095107109","https://openalex.org/W3165576985","https://openalex.org/W3198662397","https://openalex.org/W3204360130","https://openalex.org/W4294052967","https://openalex.org/W4294862258","https://openalex.org/W4304196243","https://openalex.org/W4306411819","https://openalex.org/W4377220684","https://openalex.org/W4387142632"],"related_works":["https://openalex.org/W4281752847","https://openalex.org/W4377220684","https://openalex.org/W7129216027","https://openalex.org/W4379284233","https://openalex.org/W4362595114","https://openalex.org/W4362541078","https://openalex.org/W7140195333","https://openalex.org/W3199941080","https://openalex.org/W3168842668","https://openalex.org/W3208854942"],"abstract_inverted_index":{"PURPOSE":[0],"Poly":[1],"ADP-ribose":[2],"polymerase":[3],"inhibitors":[4],"(PARPi)":[5],"are":[6,323],"approved":[7],"for":[8,79,125,208],"patients":[9,80,140,158,184,248],"with":[10,44,81,85,159,170,185,249,276,289],"human":[11],"epidermal":[12],"growth":[13],"factor":[14],"receptor":[15],"2\u2013negative":[16],"metastatic":[17],"breast":[18],"cancer":[19],"(mBC)":[20],"and":[21,74,89,128,135,148,188,197,211,214,263,279,298],"germline":[22,52],"pathogenic/likely":[23],"pathogenic":[24],"variant":[25],"(hereafter":[26],"mutation)":[27],"in":[28,42,72,165],"the":[29,62,168],"BRCA1/":[30,46],"2":[31,47],"genes":[32,88,127],"(g":[33,55],"BRCA);":[34],"however,":[35],"clinical":[36,118],"benefit":[37,284,310],"has":[38],"also":[39],"been":[40],"demonstrated":[41],"mBC":[43,73,306],"somatic":[45],"mutations":[48,54],"(s":[49],"BRCA)":[50],"or":[51,174],"PALB2":[53,176,190,226,281,300],"PALB2).":[56],"This":[57],"study":[58],"aims":[59],"to":[60,113,142,178],"describe":[61],"genomic":[63,109],"landscape":[64],"of":[65,92,107,138,183,194,305],"homologous":[66,95],"recombination":[67,96],"repair":[68],"(HRR)":[69],"gene":[70],"alterations":[71],"assess":[75],"PARPi":[76,205,286],"treatment":[77],"outcomes":[78,136],"g":[82,161,175,189,212,221,280,290,299],"BRCA":[83,162,172,187,213,222,278,291],"compared":[84],"other":[86,200],"HRR":[87,126,201],"by":[90],"status":[91],"a":[93,316],"novel":[94],"deficiency":[97],"signature":[98],"(HRDsig).":[99],"METHODS":[100],"A":[101],"real-world":[102],"(RW)":[103],"clinico-genomic":[104],"database":[105],"(CGDB)":[106],"comprehensive":[108],"profiling":[110],"(CGP)":[111],"linked":[112],"deidentified,":[114],"electronic":[115],"health":[116],"record\u2013derived":[117],"data":[119],"was":[120,123,163,228,239],"used.":[121],"CGP":[122],"analyzed":[124],"HRDsig.":[129],"The":[130],"CGDB":[131],"enabled":[132],"cohort":[133],"characterization":[134],"analyses":[137],"177":[139,209],"exposed":[141],"PARPi.":[143,312],"RW":[144,149],"progression-free":[145],"survival":[146,151],"(rwPFS)":[147],"overall":[150],"(rwOS)":[152],"were":[153,206,219],"compared.":[154],"RESULTS":[155],"Of":[156],"28,920":[157],"mBC,":[160],"detected":[164],"3.4%,":[166],"whereas":[167],"population":[169],"any":[171],"alteration":[173],"increased":[177],"9.5%.":[179],"HRDsig+":[180,198,250],"represented":[181],"21%":[182],"mBC.":[186],"had":[191,253],"higher":[192],"levels":[193],"biallelic":[195],"loss":[196],"than":[199],"alterations.":[202,292],"Outcomes":[203],"on":[204],"assessed":[207],"patients,":[210],"s":[215,224,277,296],"BRCA/":[216],"gPALB2":[217],"cohorts":[218],"similar:":[220],"versus":[223,230,241,251],"BRCA/g":[225],"rwPFS":[227,255],"6.3":[229],"5.4":[231],"months":[232,243],"(hazard":[233],"ratio":[234],"[HR],":[235],"1.37":[236],"[0.77-2.43]);":[237],"rwOS":[238,266],"16.2":[240],"21.2":[242],"(HR,":[244],"1.45":[245],"[0.74-2.86]).":[246],"Additionally,":[247],"HRDsig\u2013":[252],"longer":[254,265],"(6.3":[256],"v":[257,268],"2.8":[258],"months;":[259,270],"HR,":[260,271],"0.62":[261],"[0.42-0.92])":[262],"numerically":[264],"(17.8":[267],"13.0":[269],"0.72":[272],"[0.46-1.14]).":[273],"CONCLUSION":[274],"Patients":[275],"derive":[282],"similar":[283],"from":[285,311],"as":[287,321],"those":[288],"In":[293],"combination,":[294],"HRDsig+,":[295],"BRCA,":[297],"represent":[301],"an":[302],"additional":[303],"19%":[304],"that":[307],"can":[308],"potentially":[309],"Randomized":[313],"trials":[314],"exploring":[315],"more":[317],"inclusive":[318],"biomarker":[319],"such":[320],"HRDsig":[322],"warranted.":[324]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-11-23T00:00:00"}